The diluent type and volume are specified by the product's SmPC
Molecular Characteristics Molecular Type: Synthetic short-chain neuropeptide Structure: Linear peptide composed of nine amino acids CAS Identifier: 62568-57-4 Form: Lyophilized powder Molecular Weight: Approximately 848.9 Da Stability: High under recommended laboratory storage conditions Stability Profile and Storage Recommendations Supplied as a lyophilized powder to maintain molecular integrity Recommended storage temperature: 20C Protect from moisture and direct light exposure Avoid repeated freezethaw cycles Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Laboratory Compatibility Bacteriostatic water Sterile saline solutions Mild acidic laboratory buffers Selected organic analytical solvents Technical Specifications product Name DSIP 5mg brand BioPeptides cas 62568-57-4 purity 99% (HPLC verified) unit Size 5 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic neuropeptide stability High when stored appropriately Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity verification Mass Spectrometry molecular identity confirmation UV spectrophotometric concentration analysis Batch-to-batch consistency validation Endotoxin and microbial contamination screening Regulatory and Usage Statement DSIP 5mg supplied by BioPeptides is intended strictly for laboratory research and scientific investigation
Platelet-Rich Plasma (PRP) injections are a popular treatment for sports injuries, joint pain, and tissue healing, thanks to their ability to use the bodys own growth factors to repair damage
La seguridad durante el embarazo o la lactancia an no se encuentra completamente establecida, por lo que se desaconseja su uso en estas etapas sin supervisin mdica
What age should you start Juvederm
13 More research is needed to delineate the effects of GLP-1RAs in the various glaucoma subtypes, including neovascular glaucoma
